Thermo Fisher Scientific to Acquire Clario Holdings for $8.9B to Deepen Clinical Insights and Accelerate Drug Development

Waltham, MA, October 29, 2025 (Business Wire) -- Thermo Fisher Scientific announced a definitive agreement to acquire Clario Holdings, a global leader in digital clinical endpoint data solutions, for $8.875 billion in cash plus potential earnouts. The acquisition enhances Thermo Fisher’s capabilities in AI-driven clinical data integration, enabling pharma and biotech clients to accelerate innovation through deeper, faster insights. Expected to close mid-2026, the deal will be immediately accretive to adjusted EPS and deliver an estimated $175 million in operating synergies within five years.

Read full article here.